Although DRD2 knockout does not abrogate the anti-cancer effect of imipridones, enhanced DRD2/DRD5 heterodimerization was inversely correlated with tumor cell sensitivity to ONC201 [187,188]. The gene discussed is DRD2; the disease is cancer.